The global Valacyclovir Hcl API market size was valued at US$ million in 2024 and is forecast to a readjusted size of USD million by 2031 with a CAGR of %during review period.
Valacyclovir hydrochloride(CAS锛�136489-37-7) is an antiviral prescription medicine.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report is a detailed and comprehensive analysis for global Valacyclovir Hcl API market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Valacyclovir Hcl API market size and forecasts, in consumption value ($ Million), sales quantity (Kg), and average selling prices (US$/Kg), 2020-2031
Global Valacyclovir Hcl API market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Kg), and average selling prices (US$/Kg), 2020-2031
Global Valacyclovir Hcl API market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Kg), and average selling prices (US$/Kg), 2020-2031
Global Valacyclovir Hcl API market shares of main players, shipments in revenue ($ Million), sales quantity (Kg), and ASP (US$/Kg), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Valacyclovir Hcl API
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Valacyclovir Hcl API market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Hikal, Teva, Shanghai Pharma Group Changzhou Kony Pharmaceutical Co., Ltd., Hubei Yitai Pharmaceutical, Divis Laboratories Ltd., Jubilant Generics, Hetero Drugs, Shilpa Medicare, Anhui HaiKang Pharmaceutical, Dasami Lab, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Valacyclovir Hcl API market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Above 98 %
Above 99 %
Market segment by Application
Tablets
Others
Major players covered
Hikal
Teva
Shanghai Pharma Group Changzhou Kony Pharmaceutical Co., Ltd.
Hubei Yitai Pharmaceutical
Divis Laboratories Ltd.
Jubilant Generics
Hetero Drugs
Shilpa Medicare
Anhui HaiKang Pharmaceutical
Dasami Lab
Srini Pharmaceuticals
DEAFARMA
Kongo Chemical Co., Ltd.
Osaka Synthetic Chemical
Zhejiang Charioteer Pharmaceutical Co.,Ltd.
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Valacyclovir Hcl API product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Valacyclovir Hcl API, with price, sales quantity, revenue, and global market share of Valacyclovir Hcl API from 2020 to 2025.
Chapter 3, the Valacyclovir Hcl API competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Valacyclovir Hcl API breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Valacyclovir Hcl API market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Valacyclovir Hcl API.
Chapter 14 and 15, to describe Valacyclovir Hcl API sales channel, distributors, customers, research findings and conclusion.
Please Note - This is an on demand report and will be delivered in 2 business days (48 Hours) post payment.
1 Market Overview
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Valacyclovir Hcl API Consumption Value by Type: 2020 Versus 2024 Versus 2031
1.3.2 Above 98 %
1.3.3 Above 99 %
1.4 Market Analysis by Application
1.4.1 Overview: Global Valacyclovir Hcl API Consumption Value by Application: 2020 Versus 2024 Versus 2031
1.4.2 Tablets
1.4.3 Others
1.5 Global Valacyclovir Hcl API Market Size & Forecast
1.5.1 Global Valacyclovir Hcl API Consumption Value (2020 & 2024 & 2031)
1.5.2 Global Valacyclovir Hcl API Sales Quantity (2020-2031)
1.5.3 Global Valacyclovir Hcl API Average Price (2020-2031)
2 Manufacturers Profiles
2.1 Hikal
2.1.1 Hikal Details
2.1.2 Hikal Major Business
2.1.3 Hikal Valacyclovir Hcl API Product and Services
2.1.4 Hikal Valacyclovir Hcl API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.1.5 Hikal Recent Developments/Updates
2.2 Teva
2.2.1 Teva Details
2.2.2 Teva Major Business
2.2.3 Teva Valacyclovir Hcl API Product and Services
2.2.4 Teva Valacyclovir Hcl API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.2.5 Teva Recent Developments/Updates
2.3 Shanghai Pharma Group Changzhou Kony Pharmaceutical Co., Ltd.
2.3.1 Shanghai Pharma Group Changzhou Kony Pharmaceutical Co., Ltd. Details
2.3.2 Shanghai Pharma Group Changzhou Kony Pharmaceutical Co., Ltd. Major Business
2.3.3 Shanghai Pharma Group Changzhou Kony Pharmaceutical Co., Ltd. Valacyclovir Hcl API Product and Services
2.3.4 Shanghai Pharma Group Changzhou Kony Pharmaceutical Co., Ltd. Valacyclovir Hcl API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.3.5 Shanghai Pharma Group Changzhou Kony Pharmaceutical Co., Ltd. Recent Developments/Updates
2.4 Hubei Yitai Pharmaceutical
2.4.1 Hubei Yitai Pharmaceutical Details
2.4.2 Hubei Yitai Pharmaceutical Major Business
2.4.3 Hubei Yitai Pharmaceutical Valacyclovir Hcl API Product and Services
2.4.4 Hubei Yitai Pharmaceutical Valacyclovir Hcl API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.4.5 Hubei Yitai Pharmaceutical Recent Developments/Updates
2.5 Divis Laboratories Ltd.
2.5.1 Divis Laboratories Ltd. Details
2.5.2 Divis Laboratories Ltd. Major Business
2.5.3 Divis Laboratories Ltd. Valacyclovir Hcl API Product and Services
2.5.4 Divis Laboratories Ltd. Valacyclovir Hcl API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.5.5 Divis Laboratories Ltd. Recent Developments/Updates
2.6 Jubilant Generics
2.6.1 Jubilant Generics Details
2.6.2 Jubilant Generics Major Business
2.6.3 Jubilant Generics Valacyclovir Hcl API Product and Services
2.6.4 Jubilant Generics Valacyclovir Hcl API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.6.5 Jubilant Generics Recent Developments/Updates
2.7 Hetero Drugs
2.7.1 Hetero Drugs Details
2.7.2 Hetero Drugs Major Business
2.7.3 Hetero Drugs Valacyclovir Hcl API Product and Services
2.7.4 Hetero Drugs Valacyclovir Hcl API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.7.5 Hetero Drugs Recent Developments/Updates
2.8 Shilpa Medicare
2.8.1 Shilpa Medicare Details
2.8.2 Shilpa Medicare Major Business
2.8.3 Shilpa Medicare Valacyclovir Hcl API Product and Services
2.8.4 Shilpa Medicare Valacyclovir Hcl API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.8.5 Shilpa Medicare Recent Developments/Updates
2.9 Anhui HaiKang Pharmaceutical
2.9.1 Anhui HaiKang Pharmaceutical Details
2.9.2 Anhui HaiKang Pharmaceutical Major Business
2.9.3 Anhui HaiKang Pharmaceutical Valacyclovir Hcl API Product and Services
2.9.4 Anhui HaiKang Pharmaceutical Valacyclovir Hcl API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.9.5 Anhui HaiKang Pharmaceutical Recent Developments/Updates
2.10 Dasami Lab
2.10.1 Dasami Lab Details
2.10.2 Dasami Lab Major Business
2.10.3 Dasami Lab Valacyclovir Hcl API Product and Services
2.10.4 Dasami Lab Valacyclovir Hcl API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.10.5 Dasami Lab Recent Developments/Updates
2.11 Srini Pharmaceuticals
2.11.1 Srini Pharmaceuticals Details
2.11.2 Srini Pharmaceuticals Major Business
2.11.3 Srini Pharmaceuticals Valacyclovir Hcl API Product and Services
2.11.4 Srini Pharmaceuticals Valacyclovir Hcl API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.11.5 Srini Pharmaceuticals Recent Developments/Updates
2.12 DEAFARMA
2.12.1 DEAFARMA Details
2.12.2 DEAFARMA Major Business
2.12.3 DEAFARMA Valacyclovir Hcl API Product and Services
2.12.4 DEAFARMA Valacyclovir Hcl API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.12.5 DEAFARMA Recent Developments/Updates
2.13 Kongo Chemical Co., Ltd.
2.13.1 Kongo Chemical Co., Ltd. Details
2.13.2 Kongo Chemical Co., Ltd. Major Business
2.13.3 Kongo Chemical Co., Ltd. Valacyclovir Hcl API Product and Services
2.13.4 Kongo Chemical Co., Ltd. Valacyclovir Hcl API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.13.5 Kongo Chemical Co., Ltd. Recent Developments/Updates
2.14 Osaka Synthetic Chemical
2.14.1 Osaka Synthetic Chemical Details
2.14.2 Osaka Synthetic Chemical Major Business
2.14.3 Osaka Synthetic Chemical Valacyclovir Hcl API Product and Services
2.14.4 Osaka Synthetic Chemical Valacyclovir Hcl API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.14.5 Osaka Synthetic Chemical Recent Developments/Updates
2.15 Zhejiang Charioteer Pharmaceutical Co.,Ltd.
2.15.1 Zhejiang Charioteer Pharmaceutical Co.,Ltd. Details
2.15.2 Zhejiang Charioteer Pharmaceutical Co.,Ltd. Major Business
2.15.3 Zhejiang Charioteer Pharmaceutical Co.,Ltd. Valacyclovir Hcl API Product and Services
2.15.4 Zhejiang Charioteer Pharmaceutical Co.,Ltd. Valacyclovir Hcl API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.15.5 Zhejiang Charioteer Pharmaceutical Co.,Ltd. Recent Developments/Updates
3 Competitive Environment: Valacyclovir Hcl API by Manufacturer
3.1 Global Valacyclovir Hcl API Sales Quantity by Manufacturer (2020-2025)
3.2 Global Valacyclovir Hcl API Revenue by Manufacturer (2020-2025)
3.3 Global Valacyclovir Hcl API Average Price by Manufacturer (2020-2025)
3.4 Market Share Analysis (2024)
3.4.1 Producer Shipments of Valacyclovir Hcl API by Manufacturer Revenue ($MM) and Market Share (%): 2024
3.4.2 Top 3 Valacyclovir Hcl API Manufacturer Market Share in 2024
3.4.3 Top 6 Valacyclovir Hcl API Manufacturer Market Share in 2024
3.5 Valacyclovir Hcl API Market: Overall Company Footprint Analysis
3.5.1 Valacyclovir Hcl API Market: Region Footprint
3.5.2 Valacyclovir Hcl API Market: Company Product Type Footprint
3.5.3 Valacyclovir Hcl API Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Valacyclovir Hcl API Market Size by Region
4.1.1 Global Valacyclovir Hcl API Sales Quantity by Region (2020-2031)
4.1.2 Global Valacyclovir Hcl API Consumption Value by Region (2020-2031)
4.1.3 Global Valacyclovir Hcl API Average Price by Region (2020-2031)
4.2 North America Valacyclovir Hcl API Consumption Value (2020-2031)
4.3 Europe Valacyclovir Hcl API Consumption Value (2020-2031)
4.4 Asia-Pacific Valacyclovir Hcl API Consumption Value (2020-2031)
4.5 South America Valacyclovir Hcl API Consumption Value (2020-2031)
4.6 Middle East & Africa Valacyclovir Hcl API Consumption Value (2020-2031)
5 Market Segment by Type
5.1 Global Valacyclovir Hcl API Sales Quantity by Type (2020-2031)
5.2 Global Valacyclovir Hcl API Consumption Value by Type (2020-2031)
5.3 Global Valacyclovir Hcl API Average Price by Type (2020-2031)
6 Market Segment by Application
6.1 Global Valacyclovir Hcl API Sales Quantity by Application (2020-2031)
6.2 Global Valacyclovir Hcl API Consumption Value by Application (2020-2031)
6.3 Global Valacyclovir Hcl API Average Price by Application (2020-2031)
7 North America
7.1 North America Valacyclovir Hcl API Sales Quantity by Type (2020-2031)
7.2 North America Valacyclovir Hcl API Sales Quantity by Application (2020-2031)
7.3 North America Valacyclovir Hcl API Market Size by Country
7.3.1 North America Valacyclovir Hcl API Sales Quantity by Country (2020-2031)
7.3.2 North America Valacyclovir Hcl API Consumption Value by Country (2020-2031)
7.3.3 United States Market Size and Forecast (2020-2031)
7.3.4 Canada Market Size and Forecast (2020-2031)
7.3.5 Mexico Market Size and Forecast (2020-2031)
8 Europe
8.1 Europe Valacyclovir Hcl API Sales Quantity by Type (2020-2031)
8.2 Europe Valacyclovir Hcl API Sales Quantity by Application (2020-2031)
8.3 Europe Valacyclovir Hcl API Market Size by Country
8.3.1 Europe Valacyclovir Hcl API Sales Quantity by Country (2020-2031)
8.3.2 Europe Valacyclovir Hcl API Consumption Value by Country (2020-2031)
8.3.3 Germany Market Size and Forecast (2020-2031)
8.3.4 France Market Size and Forecast (2020-2031)
8.3.5 United Kingdom Market Size and Forecast (2020-2031)
8.3.6 Russia Market Size and Forecast (2020-2031)
8.3.7 Italy Market Size and Forecast (2020-2031)
9 Asia-Pacific
9.1 Asia-Pacific Valacyclovir Hcl API Sales Quantity by Type (2020-2031)
9.2 Asia-Pacific Valacyclovir Hcl API Sales Quantity by Application (2020-2031)
9.3 Asia-Pacific Valacyclovir Hcl API Market Size by Region
9.3.1 Asia-Pacific Valacyclovir Hcl API Sales Quantity by Region (2020-2031)
9.3.2 Asia-Pacific Valacyclovir Hcl API Consumption Value by Region (2020-2031)
9.3.3 China Market Size and Forecast (2020-2031)
9.3.4 Japan Market Size and Forecast (2020-2031)
9.3.5 South Korea Market Size and Forecast (2020-2031)
9.3.6 India Market Size and Forecast (2020-2031)
9.3.7 Southeast Asia Market Size and Forecast (2020-2031)
9.3.8 Australia Market Size and Forecast (2020-2031)
10 South America
10.1 South America Valacyclovir Hcl API Sales Quantity by Type (2020-2031)
10.2 South America Valacyclovir Hcl API Sales Quantity by Application (2020-2031)
10.3 South America Valacyclovir Hcl API Market Size by Country
10.3.1 South America Valacyclovir Hcl API Sales Quantity by Country (2020-2031)
10.3.2 South America Valacyclovir Hcl API Consumption Value by Country (2020-2031)
10.3.3 Brazil Market Size and Forecast (2020-2031)
10.3.4 Argentina Market Size and Forecast (2020-2031)
11 Middle East & Africa
11.1 Middle East & Africa Valacyclovir Hcl API Sales Quantity by Type (2020-2031)
11.2 Middle East & Africa Valacyclovir Hcl API Sales Quantity by Application (2020-2031)
11.3 Middle East & Africa Valacyclovir Hcl API Market Size by Country
11.3.1 Middle East & Africa Valacyclovir Hcl API Sales Quantity by Country (2020-2031)
11.3.2 Middle East & Africa Valacyclovir Hcl API Consumption Value by Country (2020-2031)
11.3.3 Turkey Market Size and Forecast (2020-2031)
11.3.4 Egypt Market Size and Forecast (2020-2031)
11.3.5 Saudi Arabia Market Size and Forecast (2020-2031)
11.3.6 South Africa Market Size and Forecast (2020-2031)
12 Market Dynamics
12.1 Valacyclovir Hcl API Market Drivers
12.2 Valacyclovir Hcl API Market Restraints
12.3 Valacyclovir Hcl API Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 Raw Material and Industry Chain
13.1 Raw Material of Valacyclovir Hcl API and Key Manufacturers
13.2 Manufacturing Costs Percentage of Valacyclovir Hcl API
13.3 Valacyclovir Hcl API Production Process
13.4 Industry Value Chain Analysis
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Valacyclovir Hcl API Typical Distributors
14.3 Valacyclovir Hcl API Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
Hikal
Teva
Shanghai Pharma Group Changzhou Kony Pharmaceutical Co., Ltd.
Hubei Yitai Pharmaceutical
Divis Laboratories Ltd.
Jubilant Generics
Hetero Drugs
Shilpa Medicare
Anhui HaiKang Pharmaceutical
Dasami Lab
Srini Pharmaceuticals
DEAFARMA
Kongo Chemical Co., Ltd.
Osaka Synthetic Chemical
Zhejiang Charioteer Pharmaceutical Co.,Ltd.
听
听
*If Applicable.
